Financials data is unavailable for this security.
View more
Year on year Sakar Healthcare Ltd had net income fall -8.53% from 127.59m to 116.71m despite a 14.99% increase in revenues from 1.33bn to 1.53bn. An increase in the selling, general and administrative costs as a percentage of sales from 12.79% to 13.33% was a component in the falling net income despite rising revenues.
| Gross margin | 45.62% |
|---|---|
| Net profit margin | 7.22% |
| Operating margin | 13.79% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Sakar Healthcare Ltd increased its cash reserves by 399.04%, or 3.72m. Cash Flow from Financing totalled 274.45m or 17.90% of revenues. In addition the company generated 244.67m in cash from operations while cash used for investing totalled 515.39m.
| Cash flow per share | 13.80 |
|---|---|
| Price/Cash flow per share | 23.95 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items dropped -15.76%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| EPS growth(5 years) | 2.91 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -21.34 |
